Coordinating center for continuation of follow-up of DES-exposed cohorts, can# 6-8333405, PSC#R408, period of performance 9/30/2016 to 4/29/2016
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201600032C
- Awardee
-
Westat, Inc. UEI NVUWAFWQ57S5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $699,447
Award facts
- Opportunity
-
- N02CP5101870 Solicitation number
- Coordinating Center for Continuation of Follow-Up of DES-Exposed Cohorts Award Notice · Posted Feb 25, 2016
- Contract value 81% obligated
-
- $699,447.03 Current, with exercised options
- $862,679.20 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$9,409 | |
| Funding Only Action | -$30,236 | |
| Other Administrative Action | -$330 | |
| Funding Only Action | -$22,136 | |
| Exercise an Option | $73,591 | |
| Funding Only Action | $59,316 | |
| Exercise an Option | $59,316 | |
| Funding Only Action | $51,036 | |
| Exercise an Option | $80,000 | |
| Funding Only Action | $25,000 | |
| Funding Only Action | $15,000 | |
| Funding Only Action | -$55,000 | |
| Exercise an Option | $257,357 | |
| Original award | $195,942 |
Show all 14
About this award
The National Cancer Institute awarded a definitive contract to Westat, Inc. for the Coordinating Center for Continuation of Follow-Up of DES-Exposed Cohorts on September 30, 2016, with a ceiling value of $862,679.20.
The contract carries cost-plus-fixed-fee pricing and runs through April 29, 2021. Place of performance is Rockville, MD 20850. The work involves ongoing coordination and follow-up activities for cohorts exposed to diethylstilbestrol (DES), a synthetic estrogen historically administered during pregnancy. No set-aside was used in this award.
Quick answers
Who was awarded contract HHSN261201600032C?
HHSN261201600032C was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2016.
How much is contract HHSN261201600032C worth?
The government has obligated $699,447 on HHSN261201600032C. Its potential value, with all options, is $862,679.
Was contract HHSN261201600032C competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award